Missouri Bayer Suit update
Only Missourians Allowed to Remain in Bayer Essure Suit
July 17, 2017
A federal judge in Missouri has barred residents of all other states from a lawsuit against pharmaceutical giant Bayer concerning the health risks of its Essure birth control device, stating that fully 86 of the women do not meet jurisdictional requirements.
Only eight of the 94 plaintiffs – that is, those who reside in Missouri or who had their Essure devices implanted in Missouri – may remain in the lawsuit, ruled judge Carol E. Jackson. Women from 25 states had originally filed suit against Bayer.
Essure is a device that contains two coils which are implanted into a woman’s fallopian tube. Central to the lawsuit is the claim that women who receive the Essure implant are up to 10 times more likely to require additional, corrective surgical procedures. Though the U.S. Food and Drug Administration (FDA) has issued a so-called “black box” warning about the device, it has permitted Essure to remain on the market.
Plaintiffs further claim that the device’s original maker, a company named Conceptus, had lied about Essure’s safety in order to obtain greater profits. Bayer purchased Conceptus for $1.1 billion in 2013; the suits claim that Bayer provided false or misleading information about Essure.
If you have been implanted with an Essure birth-control device, and have required subsequent corrective surgeries, you may be entitled to compensation. Contact the expert attorneys at TheLawFirm.com to learn how we can help you.
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!